Isaka Kansai, JP
Common concerns regarding safety, legality, and side effects are addressed, and the article closes by highlighting the growing trend toward biohacking weight loss, metabolic reset programs, and personalized peptide-based therapies
If youre joining from another provider, we may ask for evidence of your previous treatment or starting weight
These findings highlight the urgent need for evidence-based guidance for when GLP-1RAs should be used relative to bariatric surgery in adolescents and young adults, including whether medications are most effective before surgery, after surgery, or as part of combination therapy. Other UTSW researchers who contributed to this study are senior author Sarah Barlow, M.D., M.P.H., Professor of Pediatrics
Whether you choose to cover GLP-1s or not, these medications represent a broader shift in how obesity and weight-related chronic conditions are treated
Therefore, 75 RCTs with 21,806 participants were included in our analysis set (Table S2), while 59 studies with 13,322 patients were obtained for the meta-analysis and NMA
